Certara Inc

:CERT

26.36

-4.16 (-13.63%)

Market Cap (Intraday)	3.16B
Current PE	N/A
Forward PE	155.06
2yr Forward PE	97.63

See more stats

Estimates Current Quarter

Revenue	$64.52 Million
Adjusted EPS	$0.04

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Certara, Inc. Stock, :CERT

100 Overlook Center, Suite 101, Princeton, New Jersey 08540

United States of America

Phone: +1.609.716.7900

Number of Employees:

http://www.certara.com

Description

Certara, Inc. engages in the provision of software and technology enables services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Princeton, NJ.